Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma

Ellen T. Chang, Tongzhang Zheng, Evelyne T. Lennette, Edward G. Weir, Michael J Borowitz, Risa B. Mann, Donna Spiegelman, Nancy E. Mueller

Research output: Contribution to journalArticle

Abstract

Background. Hodgkin lymphoma (HL) tumors that contain the Epstein-Barr virus (EBV) genome may differ etiologically from EBV-negative HL tumors. Methods. A case-case study examining heterogeneity of risk factors between disease subgroups compared personal characteristics and EBV antibodies between 95 EBV-positive and 303 EBV-negative patients with HL. Results. We confirmed previous associations of EBV-positive HL with older age, male sex, and mixed-cellularity (MC) histological subtypes. EBV-positive patients were less educated and more likely to have smoked cigarettes and had more prevalent and higher EBV antibody titers, compared with EBV-negative patients. After adjustment for all independent risk factors, those most strongly associated with EBV-positive HL were histological subtypes (odds ratio [OR] for MC vs. nodular sclerosis histology, 3.2; 95% confidence interval [CI], 1.4-7.2), elevated anti-viral capsid antigen level (OR, 3.1; 95% CI, 1.6-6.0), and less education (OR, 0.7; 95% CI, 0.5-1.0). Cigarette smoking and a low anti-Epstein-Barr nuclear protein (EBNA) 1:anti-EBNA-2 ratio were also marginally associated with EBV-positive HL. Conclusions. EBV-positive HL is more common among individuals who have markers of diminished cellular immunity and an abnormal EBV antibody response. EBV appears to participate in the etiology of EBV-positive HL but may not be involved in EBV-negative HL.

Original languageEnglish (US)
Pages (from-to)2271-2281
Number of pages11
JournalJournal of Infectious Diseases
Volume189
Issue number12
DOIs
StatePublished - Jun 15 2004

Fingerprint

Human Herpesvirus 4
Hodgkin Disease
Genome
Antibodies
Odds Ratio
Confidence Intervals
Nuclear Proteins
Viral Antigens
Capsid
Sclerosis
Viral Load
Cellular Immunity
Tobacco Products
Antibody Formation
Neoplasms
Histology

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Immunology

Cite this

Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. / Chang, Ellen T.; Zheng, Tongzhang; Lennette, Evelyne T.; Weir, Edward G.; Borowitz, Michael J; Mann, Risa B.; Spiegelman, Donna; Mueller, Nancy E.

In: Journal of Infectious Diseases, Vol. 189, No. 12, 15.06.2004, p. 2271-2281.

Research output: Contribution to journalArticle

Chang, Ellen T. ; Zheng, Tongzhang ; Lennette, Evelyne T. ; Weir, Edward G. ; Borowitz, Michael J ; Mann, Risa B. ; Spiegelman, Donna ; Mueller, Nancy E. / Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. In: Journal of Infectious Diseases. 2004 ; Vol. 189, No. 12. pp. 2271-2281.
@article{bc60b7597e0646118643384111187bff,
title = "Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma",
abstract = "Background. Hodgkin lymphoma (HL) tumors that contain the Epstein-Barr virus (EBV) genome may differ etiologically from EBV-negative HL tumors. Methods. A case-case study examining heterogeneity of risk factors between disease subgroups compared personal characteristics and EBV antibodies between 95 EBV-positive and 303 EBV-negative patients with HL. Results. We confirmed previous associations of EBV-positive HL with older age, male sex, and mixed-cellularity (MC) histological subtypes. EBV-positive patients were less educated and more likely to have smoked cigarettes and had more prevalent and higher EBV antibody titers, compared with EBV-negative patients. After adjustment for all independent risk factors, those most strongly associated with EBV-positive HL were histological subtypes (odds ratio [OR] for MC vs. nodular sclerosis histology, 3.2; 95{\%} confidence interval [CI], 1.4-7.2), elevated anti-viral capsid antigen level (OR, 3.1; 95{\%} CI, 1.6-6.0), and less education (OR, 0.7; 95{\%} CI, 0.5-1.0). Cigarette smoking and a low anti-Epstein-Barr nuclear protein (EBNA) 1:anti-EBNA-2 ratio were also marginally associated with EBV-positive HL. Conclusions. EBV-positive HL is more common among individuals who have markers of diminished cellular immunity and an abnormal EBV antibody response. EBV appears to participate in the etiology of EBV-positive HL but may not be involved in EBV-negative HL.",
author = "Chang, {Ellen T.} and Tongzhang Zheng and Lennette, {Evelyne T.} and Weir, {Edward G.} and Borowitz, {Michael J} and Mann, {Risa B.} and Donna Spiegelman and Mueller, {Nancy E.}",
year = "2004",
month = "6",
day = "15",
doi = "10.1086/420886",
language = "English (US)",
volume = "189",
pages = "2271--2281",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma

AU - Chang, Ellen T.

AU - Zheng, Tongzhang

AU - Lennette, Evelyne T.

AU - Weir, Edward G.

AU - Borowitz, Michael J

AU - Mann, Risa B.

AU - Spiegelman, Donna

AU - Mueller, Nancy E.

PY - 2004/6/15

Y1 - 2004/6/15

N2 - Background. Hodgkin lymphoma (HL) tumors that contain the Epstein-Barr virus (EBV) genome may differ etiologically from EBV-negative HL tumors. Methods. A case-case study examining heterogeneity of risk factors between disease subgroups compared personal characteristics and EBV antibodies between 95 EBV-positive and 303 EBV-negative patients with HL. Results. We confirmed previous associations of EBV-positive HL with older age, male sex, and mixed-cellularity (MC) histological subtypes. EBV-positive patients were less educated and more likely to have smoked cigarettes and had more prevalent and higher EBV antibody titers, compared with EBV-negative patients. After adjustment for all independent risk factors, those most strongly associated with EBV-positive HL were histological subtypes (odds ratio [OR] for MC vs. nodular sclerosis histology, 3.2; 95% confidence interval [CI], 1.4-7.2), elevated anti-viral capsid antigen level (OR, 3.1; 95% CI, 1.6-6.0), and less education (OR, 0.7; 95% CI, 0.5-1.0). Cigarette smoking and a low anti-Epstein-Barr nuclear protein (EBNA) 1:anti-EBNA-2 ratio were also marginally associated with EBV-positive HL. Conclusions. EBV-positive HL is more common among individuals who have markers of diminished cellular immunity and an abnormal EBV antibody response. EBV appears to participate in the etiology of EBV-positive HL but may not be involved in EBV-negative HL.

AB - Background. Hodgkin lymphoma (HL) tumors that contain the Epstein-Barr virus (EBV) genome may differ etiologically from EBV-negative HL tumors. Methods. A case-case study examining heterogeneity of risk factors between disease subgroups compared personal characteristics and EBV antibodies between 95 EBV-positive and 303 EBV-negative patients with HL. Results. We confirmed previous associations of EBV-positive HL with older age, male sex, and mixed-cellularity (MC) histological subtypes. EBV-positive patients were less educated and more likely to have smoked cigarettes and had more prevalent and higher EBV antibody titers, compared with EBV-negative patients. After adjustment for all independent risk factors, those most strongly associated with EBV-positive HL were histological subtypes (odds ratio [OR] for MC vs. nodular sclerosis histology, 3.2; 95% confidence interval [CI], 1.4-7.2), elevated anti-viral capsid antigen level (OR, 3.1; 95% CI, 1.6-6.0), and less education (OR, 0.7; 95% CI, 0.5-1.0). Cigarette smoking and a low anti-Epstein-Barr nuclear protein (EBNA) 1:anti-EBNA-2 ratio were also marginally associated with EBV-positive HL. Conclusions. EBV-positive HL is more common among individuals who have markers of diminished cellular immunity and an abnormal EBV antibody response. EBV appears to participate in the etiology of EBV-positive HL but may not be involved in EBV-negative HL.

UR - http://www.scopus.com/inward/record.url?scp=2942564310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942564310&partnerID=8YFLogxK

U2 - 10.1086/420886

DO - 10.1086/420886

M3 - Article

C2 - 15181575

AN - SCOPUS:2942564310

VL - 189

SP - 2271

EP - 2281

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 12

ER -